KwdFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « KwdFr.i » - entrée « Anticorps monoclonaux (administration et posologie) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anticorps monoclonaux () < Anticorps monoclonaux (administration et posologie) < Anticorps monoclonaux (analyse)  Facettes :

List of bibliographic references indexed by Anticorps monoclonaux (administration et posologie)

Number of relevant bibliographic references: 73.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
001087 (2018) Fusao Komada ; Yuko Nakayama ; Kohji Takara[Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents].
001179 (2018) Erin Murray ; Alexandra Ellis ; Yekaterina Butylkova ; Martha Skup [États-Unis] ; Jasmina Kalabic [Allemagne] ; Vishvas Garg [États-Unis]Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis.
001323 (2018) Abdul Rafeh Naqash [États-Unis] ; Li V. Yang [États-Unis] ; Edward J. Sanderlin [États-Unis] ; Druid C. Atwell [États-Unis] ; Paul R. Walker [États-Unis]Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report.
001410 (2018) K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne]ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
001622 (2017) Charles SchmidtThe struggle to do no harm in clinical trials.
001885 (2017) Michele M. Luchetti [Italie] ; Devis Benfaremo [Italie] ; Armando Gabrielli [Italie]Biologics in Inflammatory and Immunomediated Arthritis.
001886 (2017) Gianluca Moroncini [Italie] ; Giovanni Calogera [Italie] ; Devis Benfaremo [Italie] ; Armando Gabrielli [Italie]Biologics in Inflammatory Immune-mediated Systemic Diseases.
001915 (2017) Wilmar M. Wiersinga [Pays-Bas]Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
001954 (2016) Syuji Takei[Diagnosis and treatment of juvenile idiopathic arthritis (JIA)].
002004 (2015) Jie Zhang ; Fenglong Xie ; Elizabeth Delzell ; Huifeng Yun ; James D. Lewis ; Kevin Haynes ; Lang Chen ; Timothy Beukelman ; Kenneth G. Saag ; Jeffrey R. CurtisImpact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.
002090 (2015) David Ternant [France] ; Theodora Bejan-Angoulvant [France] ; Christophe Passot [France] ; Denis Mulleman [France] ; Gilles Paintaud [France]Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.
002095 (2015) Francesco La Torre [Italie] ; Maurizio Muratore [Italie] ; Antonio Vitale [Italie] ; Fulvio Moramarco [Italie] ; Laura Quarta [Italie] ; Luca Cantarini [Italie]Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
002266 (2014) A S Avdeev ; A A Novikov ; E N Aleksandrova ; E Iu Panasiuk ; E L Nasonov[The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis].
002315 (2014) Emmett T. Cunningham [États-Unis] ; Manfred ZierhutThe promise and limitations of TNF-α inhibition for uveitis.
002323 (2014) Anshuman P. Malaviya [Royaume-Uni] ; Jo Ledingham [Royaume-Uni] ; Jill Bloxham [Royaume-Uni] ; Aisla Bosworth [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Ernest Choy [Royaume-Uni] ; Andrew Cope [Royaume-Uni] ; John Isaacs [Royaume-Uni] ; David Marshall [Royaume-Uni] ; Gary Wright [Royaume-Uni] ; Andrew J K. Ostör [Royaume-Uni]The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.
002343 (2014) Alan Kivitz [États-Unis] ; Ewa Olech ; Michael Borofsky ; Beatriz M. Zazueta ; Federico Navarro-Sarabia ; Sebastião C. Radominski ; Joan T. Merrill ; Lucy Rowell ; Clare Nasmyth-Miller ; Min Bao ; Stephen Wright ; Janet E. PopeSubcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
002359 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiRetreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
002652 (2013) Said Younis [Israël] ; Itzhak Rosner ; Doron Rimar ; Nina Boulman ; Michael Rozenbaum ; Majed Odeh ; Gleb SlobodinWeight change during pharmacological blockade of interleukin-6 or tumor necrosis factor-α in patients with inflammatory rheumatic disorders: a 16-week comparative study.
002717 (2013) Ricardo Prado Golmia ; Morton Aaron ScheinbergRetention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital.
002718 (2013) Y. Hishitani [Japon] ; A. Ogata ; Y. Shima ; T. Hirano ; K. Ebina ; Y. Kunugiza ; K. Shi ; M. Narazaki ; K. Hagihara ; T. Tomita ; H. Yoshikawa ; T. Tanaka ; A. KumanogohRetention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis.
002799 (2013) Hideaki Yamakawa [Japon] ; Noboru Takayanagi ; Takashi Ishiguro ; Tetsu Kanauchi ; Toshiko Hoshi ; Yutaka SugitaClinical investigation of nontuberculous mycobacterial lung disease in Japanese patients with rheumatoid arthritis receiving biologic therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Anticorps monoclonaux (administration et posologie)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Anticorps monoclonaux (administration et posologie)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Anticorps monoclonaux (administration et posologie)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021